Home Tags Vaccinations
Vaccinations Related Content
The role of pharmacy during COVID-19
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
COVID-19: Solidarity is needed the most
European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.
European Commission buys 300 million doses of Pfizer vaccine
While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.
The Pfizer vaccine: When will people in the UK get it?
Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?
Pfizer vaccine is more than 90% successful in preventing COVID-19
Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.
Impact of COVID-19 on healthcare for patients with diabetes
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
ICE detention centres withheld vaccines from child migrants
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
When is the UK COVID-19 vaccine going to be ready?
While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?
Research finds hydroxychloroquine does not work against COVID-19
A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.
The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
What are Europe’s health policy priorities going forward?
Open Access Government explores the European Commission’s Department of Health and Food Safety’s response to the COVID-19 crisis and charts their next steps towards a vaccine for every European citizen.
COVID-19 antibodies decline significantly one month after discharge
A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.
Russia approves COVID-19 vaccine before completing trials
Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.
The challenges of COVID-19 human infection trials
Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.
Covid-19: Could a vaccine be available by September?
Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.
Uptake of existing vaccines will help support health systems from COVID-19 pressures
The Immunisation For All Ages group discusses the importance of protecting vaccine budgets and immunisation infrastructure, even amidst COVID-19.
Japan and EU work on strategic partnership for COVID-19 pandemic
President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.
Economic and scientific experts discuss EU response to COVID-19
Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.
Vaccine misinformation is more likely on social media
Researchers have found that people who use social media for news are more likely to experience vaccine misinformation.
Government pledges £20 million to develop new coronavirus vaccine
The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.